Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FIRST-LINE TREATMENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Biasco, G; Gallerani, E
      Treatment of liver metastases from colorectal cancer: what is the best approach today?

      DIGESTIVE AND LIVER DISEASE
    2. Midgley, R; Kerr, D
      Conventional cytotoxic and novel therapeutic concepts in colorectal cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Matheson, AJ; Nobel, S
      Management of colorectal cancer - Defining the role of raltitrexed

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    4. Grothey, A; Schmoll, HJ
      New chemotherapy approaches in colorectal cancer

      CURRENT OPINION IN ONCOLOGY
    5. Ciccone, A; Sterzi, R; Crespi, V; Defanti, CA; Pasetti, C
      Thrombolysis for acute ischemic stroke: The patient's point of view

      CEREBROVASCULAR DISEASES
    6. Lee, JH; Lee, JH; Kim, TW; Lee, KH; Kang, YK; Lee, JS; Kim, SH; Kim, HC; Yu, CS; Kim, JC; Kim, WK
      Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer

      JOURNAL OF KOREAN MEDICAL SCIENCE
    7. Comba, AZ; Blajman, C; Richardet, E; Bella, S; Vilanova, M; Coppola, F; Van Kooten, M; Rodger, J; Giglio, R; Balbiani, L; Perazzo, F; Montiel, M; Chacon, M; Pujol, F; Mickiewicz, E; Cazap, E; Recondo, G; Lastiri, F; Simon, J; Wasserman, E; Schmilovich, A
      A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previouslyuntreated metastatic colorectal cancer patients

      EUROPEAN JOURNAL OF CANCER
    8. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    9. Van Cutsem, E; Dicato, M; Wils, J
      Recent advances in the management of colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    10. Cavaletti, G; Tredici, G; Petruccioli, MG; Donde, E; Tredici, P; Marmiroli, P; Minoia, C; Ronchi, A; Bayssas, M; Etienne, GG
      Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

      EUROPEAN JOURNAL OF CANCER
    11. Rougier, P
      Palliative and adjuvant chemotherapy in colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    12. Czuczman, MS
      Combination chemotherapy and rituximab

      ANTI-CANCER DRUGS
    13. Kern, W; Beckert, B; Lang, N; Stemmler, J; Beykirch, M; Stein, J; Goecke, E; Waggershauser, T; Braess, J; Schalhorn, A; Hiddemann, W
      Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

      ANNALS OF ONCOLOGY
    14. Kohne, CH; Grothey, A; Bokemeyer, C; Bontke, N; Aapro, M
      Chemotherapy in elderly patients with colorectal cancer

      ANNALS OF ONCOLOGY
    15. Martoni, A; Mini, E; Pinto, C; Nobili, S; Gentile, AL; Dentico, P; Angelelli, B; Scicolone, S; Piana, E; Mazzei, T
      Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma

      ANNALS OF ONCOLOGY
    16. Eiermann, W
      Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data

      ANNALS OF ONCOLOGY
    17. Khayat, D; Gil-Delgado, M; Antoine, EC; Nizri, D; Bastian, G
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer

      ONCOLOGY-NEW YORK
    18. Sun, WJ; Haller, DG
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed

      ONCOLOGY-NEW YORK
    19. Haller, DG
      Update on chemotherapy for advanced colorectal cancer

      ONCOLOGY-NEW YORK
    20. Pitot, HC; Goldberg, RM
      Future directions in adjuvant therapy for stage III colon carcinoma

      ONCOLOGY-NEW YORK
    21. Lebovitz, HE
      Oral therapies for diabetic hyperglycemia

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    22. Wong, M; Trevathan, E
      Infantile spasms

      PEDIATRIC NEUROLOGY
    23. Gladstone, DJ; Black, SE
      Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    24. Beretta, GD; Pessi, MA; Poletti, P; Mosconi, S; Labianca, R
      New drugs and combinations in the palliative treatment of colon and rectalcancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    25. O'Dwyer, PJ; Manola, J; Valone, FH; Ryan, LM; Hines, JD; Wadler, S; Haller, DG; Arbuck, SG; Weiner, LM; Mayer, RJ; Benson, AB
      Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study

      JOURNAL OF CLINICAL ONCOLOGY
    26. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
      Irinotecan in the treatment of colorectal cancer: Clinical overview

      JOURNAL OF CLINICAL ONCOLOGY
    27. Becouarn, Y; Gamelin, E; Coudert, B; Negrier, S; Pierga, JY; Raoul, JL; Provencal, J; Rixe, O; Krisch, C; Germa, C; Bekradda, M; Mignard, D; Mousseau, M
      Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    28. Rothenberg, ML; Meropol, NJ; Poplin, EA; Van Cutsem, E; Wadler, S
      Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: Summary findings of an independent panel

      JOURNAL OF CLINICAL ONCOLOGY
    29. Waterhouse, DN; Dos Santos, N; Mayer, LD; Bally, MB
      Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs

      PHARMACEUTICAL RESEARCH
    30. Nolte, W; Ramadori, G
      New aspects in the palliative treatment of metastatic colorectal carcinoma

      MEDIZINISCHE KLINIK
    31. Reimer, P; Ruckle-Lanz, H
      New therapeutic options in the chemotherapy of advanced colorectal cancer

      MEDIZINISCHE KLINIK
    32. Faraone, SV; Green, AI; Seidman, LJ; Tsuang, MT
      "Schizotaxia": Clinical implications and new directions for research

      SCHIZOPHRENIA BULLETIN
    33. Louvet, C
      New chemotherapies for colorectal cancer treatment

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    34. Riikonen, R
      ACTH therapy of West syndrome: Finnish views

      BRAIN & DEVELOPMENT
    35. Wallace, SJ
      Newer antiepileptic drugs: advantages and disadvantages

      BRAIN & DEVELOPMENT
    36. Honecker, F; Wedding, U; Kolb, G; Bokemeyer, C
      Chemotherapy in colorectal cancer - Which therapy is justified in elderly patients?

      ONKOLOGIE
    37. Hartung, G
      New developments in chemotherapy of gastrointestinal carcinomas

      ONKOLOGIE
    38. Sitzung, Z; Benson, AB; Goldberg, RM
      Oxaliplatin (Eloxatin) - Advances in cancer therapy 2001 - Introduction

      ONKOLOGIE
    39. Donadio, M; Manzin, E; Berruti, A; Bottini, A; Gorzegno, G; Danese, S; DeFabiani, E; Sarobba, MG; Lorusso, V; Castiglione, F; Moro, G; Bertetto, O; Bumma, C; Dogliotti, L
      Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretrested metastatic breast cancer patients. A multicenter phase II trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    40. Bousser, MG
      Antithrombotic strategy in stroke

      THROMBOSIS AND HAEMOSTASIS
    41. Hill, MD; Buchan, AM
      Methodology for the Canadian Activase For Stroke Effectiveness Study (CASES)

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    42. Aschele, C; Sartor, L; Lonardi, S; Friso, M; Monfardini, S
      Oxaliplatin in rectal cancer. Clinical aspects: The medical oncologist point of view

      TUMORI
    43. Piedbois, P; Zelek, L; Cherqui, D
      Chemotherapy of nonoperable colorectal liver metastases

      HEPATO-GASTROENTEROLOGY
    44. Jansman, FGA; Sleijfer, DT; de Graaf, JC; Coenen, JLLM; Brouwers, JRBJ
      Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer

      DRUG SAFETY
    45. Nabbout, R
      A risk-benefit assessment of treatments for infantile spasms

      DRUG SAFETY
    46. Grivicich, I; Mans, DRA; Peters, GJ; Schwartsmann, G
      Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    47. Sargent, DJ; Niedzwiecki, D; O'Connell, MJ; Schilsky, RL
      Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

      NEW ENGLAND JOURNAL OF MEDICINE
    48. Elterman, RD; Shields, WD; Mansfield, KA; Nakagawa, J
      Randomized trial of vigabatrin in patients with infantile spasms

      NEUROLOGY
    49. Labianca, RF; Beretta, GD; Pessi, MA
      Colorectal cancer - Disease management considerations

      DRUGS
    50. Ott, R; Wein, A; Hohenberger, W
      Liver metastases - primary or multimodal therapy?

      CHIRURG
    51. Kubicka, S; Manns, MP
      Additive chemotherapy in liver metastases to improve operability

      CHIRURG
    52. Granda, TG; Filipski, E; D'Attino, RM; Vrignaud, P; Anjo, A; Bissery, MC; Levi, F
      Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination

      CANCER RESEARCH
    53. Link, KH; Sunelaitis, E; Kornmann, M; Schatz, M; Gansauge, F; Leder, G; Formentini, A; Staib, L; Pillasch, J; Beger, HG
      Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival

      CANCER
    54. Scheithauer, W; Kornek, GV; Ulrich-Pur, H; Penz, M; Raderer, M; Salek, T; Haider, K; Kwasny, W; Depisch, D
      Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial

      CANCER
    55. Louvet, C; de Gramont, A; Tournigand, C; Artru, P; Maindrault-Goebel, F; Krulik, M
      Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma

      CANCER
    56. Andre, T; Louvet, C; Maindrault-Goebel, F; de Gramont, A
      Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer

      BULLETIN DU CANCER
    57. Goldwasser, F; Misset, JL
      Clinical use of oxaliplatin in solid tumors

      BULLETIN DU CANCER
    58. Bugat, R
      Oxaliplatin: safety profile in metastatic colorectal cancer

      BULLETIN DU CANCER
    59. Spaepen, K; Stroobants, S; Dupont, P; Thomas, J; Vandenberghe, P; Balzarini, J; De Wolf-Peeters, C; Mortelmans, L; Verhoef, G
      Can positron emission tomography with [F-18]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additionaltherapy from others in whom additional therapy would mean avoidable toxicity?

      BRITISH JOURNAL OF HAEMATOLOGY
    60. Chau, I; Webb, A; Cunningham, D; Hill, M; Waters, JS; Norman, A; Massey, A
      Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer

      BRITISH JOURNAL OF CANCER
    61. Bensmaine, MA; Marty, M; de Gramont, A; Brienza, S; Levi, F; Ducreux, M; Francois, E; Gamelin, E; Bleiberg, H; Cvitkovic, E
      Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

      BRITISH JOURNAL OF CANCER
    62. Sobrero, A; Guglielmi, A; Cirillo, M; Recaldin, E; Frassineti, GL; Aschele, C; Ravaioli, A; Testore, P; Caroti, C; Gallo, L; Pessi, MA; Cortesi, E; Turci, D; Grossi, F; Labianca, R
      5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    63. Thirion, P; Piedbois, P; Buyse, M; O'Dwyer, PJ; Cunningham, D; Man, A; Greco, FA; Colucci, G; Kohne, CH; Di Costanzo, F; Piga, A; Palmeri, S; Dufour, P; Cassano, A; Pajkos, G; Pensel, R; Aykan, NF; Marsh, J; Seymour, T
      Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    64. Van Laethem, JL
      Adjuvant treatment for colorectal cancer

      ACTA GASTRO-ENTEROLOGICA BELGICA
    65. Comer, AM; Goa, KL
      Docetaxel - A review of its use in non-small cell lung cancer

      DRUGS & AGING
    66. Ciccone, A; Motto, C; Aritzu, E; Piana, A; Candelise, L
      Negative interaction of aspirin and streptokinase in acute ischemic stroke: Further analysis of the Multicenter Acute Stroke Trial-Italy

      CEREBROVASCULAR DISEASES
    67. Bogousslavsky, J; Paciaroni, M; Gallai, V
      Acute stroke treatment: Thrombolysis

      CEREBROVASCULAR DISEASES
    68. Giannakakis, T; Ziras, N; Kakolyris, S; Mavroudis, D; Androulakis, N; Agelaki, S; Parashos, M; Sarra, E; Dimou, T; Hatzidaki, D; Vlachonikolis, J; Georgoulias, V
      Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study

      EUROPEAN JOURNAL OF CANCER
    69. Riikonen, RS
      Steroids or vigabatrin in the treatment of infantile spasms?

      PEDIATRIC NEUROLOGY
    70. Lonning, PE; Bajetta, E; Murray, R; Tubiana-Hulin, M; Eisenberg, PD; Mickiewicz, E; Celio, L; Pitt, P; Mita, M; Aaronson, NK; Fowst, C; Arkhipov, A; di Salle, E; Polli, A; Massimini, G
      Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial

      JOURNAL OF CLINICAL ONCOLOGY
    71. Graf, J; Skutta, B; Kuhn, FP; Ferbert, A
      Computed tomographic angiography findings in 103 patients following vascular events in the posterior circulation: potential and clinical relevance

      JOURNAL OF NEUROLOGY
    72. Schmidt, D; Brandl, U; Elger, CE; Kramer, G; Siemes, H; Stephani, U; Aksu, F; Boenigk, HE; Froscher, W; Keimer, R; Kluger, G; Kurlemann, G; Rochel, M; Schmitz, B; Stefan, H; Stodieck, S
      The current role of vigabatrin (Sabril (R)) in the treatment of epilepsies: Results of a consensus conference

      AKTUELLE NEUROLOGIE
    73. Sweeney, CJ; Sandler, AB
      Chemotherapy in non-small cell lung cancer

      INVESTIGATIONAL NEW DRUGS
    74. Langer, CJ
      Advanced non-small cell lung carcinoma: The emerging role of docetaxel

      INVESTIGATIONAL NEW DRUGS
    75. van Toorn, DW; Nortier, JWR; Rubach, M; de Swart, CAM; Huldij, JC; van Tinteren, H; Vermorken, JB
      Randomized phase II study of FEC day 1+8 and FEC day 1 in patients with advanced breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    76. Green, AI; Patel, JK; Goisman, RM; Allison, DB; Blackburn, G
      Weight gain from novel antipsychotic drugs: Need for action

      GENERAL HOSPITAL PSYCHIATRY
    77. Katzan, IL; Furlan, AJ; Lloyd, LE; Frank, JI; Harper, DL; Hinchey, JA; Hammel, JP; Qu, A; Sila, CA
      Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    78. Kotsakis, A; Sarra, E; Peraki, M; Koukourakis, M; Apostolaki, S; Souglakos, J; Mavromanomakis, E; Vlachonikolis, J; Georgoulias, V
      Docetaxel-induced lymphopenia in patients with solid tumors - A prospective phenotypic analysis

      CANCER
    79. Tsuang, MT; Stone, WS; Faraone, SV
      Towards the prevention of schizophrenia

      BIOLOGICAL PSYCHIATRY
    80. Rother, J; Jonetz-Mentzel, L; Fiala, A; Reichenbach, JR; Herzau, M; Kaiser, WA; Weiller, C
      Hemodynamic assessment of acute stroke using dynamic single-slice computedtomographic perfusion imaging

      ARCHIVES OF NEUROLOGY
    81. Rudolf, J; Neveling, M; Grond, M; Schmulling, S; Stenzel, C; Heiss, WD
      Stroke following internal carotid artery occlusion a contra-indication forintravenous thrombolysis?

      EUROPEAN JOURNAL OF NEUROLOGY
    82. Siu, YCA; Wong, TW; Lau, CC
      Candidates for thrombolytic treatment in acute ischaemic stroke - where are our patients in Hong Kong?

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    83. Ormrod, D; Holm, K; Goa, K; Spencer, C
      Epirubicin - A review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer

      DRUGS & AGING
    84. Green, AI; Zimmet, SV; Strous, RD; Schildkraut, JJ
      Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

      HARVARD REVIEW OF PSYCHIATRY
    85. Davalos, A
      Fibrinolytic therapy for acute stroke: The Spanish experience

      CEREBROVASCULAR DISEASES
    86. Comella, P; Casaretti, R; De Vita, F; Avallone, A; Orditura, M; Petrillo, A; Gravina, A; Faranda, A; Comis, S; Comella, G; Catalano, G
      Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma:A phase I study of the Southern Italy Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    87. Leung, PP; Tannock, IF; Oza, AM; Puodziunas, A; Dranitsaris, G
      Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    88. Messori, A; Bosi, A; Bacci, S; Laszlo, D; Trippoli, S; Locatelli, F; Van Lint, MT; Di Bartolomeo, P; Amici, A
      Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia

      BONE MARROW TRANSPLANTATION
    89. Koch, C; Luiz, T; Ellinger, K; van Ackern, K; Behrens, S; Daffertshofer, M
      Pre-clinical management of acute strokes

      ANASTHESIOLOGIE & INTENSIVMEDIZIN
    90. CHATELLIER G; MARRE M
      CHOICE OF FIRST-LINE TREATMENT FOR ARTERIAL-HYPERTENSION - SHOULD DIHYDROPYRIDINES BE AVOIDED IN DIABETIC-PATIENTS

      DIABETES & METABOLISM
    91. LOEBEL AD; BOTTS SR; FELDMAN BI
      ATYPICAL ANTIPSYCHOTICS IN THE MANAGED CARE ERA

      American journal of managed care
    92. Messori, A; Trippoli, S
      Pharmacoeconomic profile of taxanes in advanced ovarian cancer

      ANTI-CANCER DRUGS
    93. RUNDE V; DEWITTE T; ARNOLD R; GRATWOHL A; HERMANS J; VANBIEZEN A; NIEDERWIESER D; LABOPIN M; WALTERNOEL MP; BACIGALUPO A; JACOBSEN N; LJUNGMAN P; CARRERAS E; KOLB HJ; AUL C; APPERLEY J
      BONE-MARROW TRANSPLANTATION FROM HLA IDENTICAL SIBLINGS AS FIRST-LINETREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - EARLY TRANSPLANTATION IS ASSOCIATED WITH IMPROVED OUTCOME

      Bone marrow transplantation
    94. BLEIBERG H
      OXALIPLATIN (L-OHP) - A NEW REALITY IN COLORECTAL-CANCER

      British Journal of Cancer
    95. CLEMONS M; LEAHY M; VALLE J; JAYSON G; RANSON M; HOWELL A
      REVIEW OF RECENT TRIALS OF CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - THE TAXANES

      European journal of cancer
    96. TROPE C; KAERN J; KRISTENSEN G; ROSENBERG P; SORBE B
      PACLITAXEL IN UNTREATED FIGO STAGE-III SUBOPTIMALLY RESECTED OVARIAN-CANCER

      Annals of oncology
    97. DUFFULL SB; ROBINSON BA
      CLINICAL PHARMACOKINETICS AND DOSE OPTIMIZATION OF CARBOPLATIN

      Clinical pharmacokinetics
    98. COUKELL AJ; FAULDS D
      EPIRUBICIN - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF BREAST-CANCER

      Drugs
    99. TRUDEAU ME
      FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER

      Anti-cancer drugs
    100. GARCIACONDE J; LLUCH A; MARTIN M; CASADO A; GERVASIO H; DEOLIVEIRA C; DEPABLO JL; GOROSTIAGA J; GIRON GC; CERVANTES A; MARTINEZ A; PEZOUS N; DELGADO FM; RUBIO ED
      PHASE-II TRIAL OF WEEKLY IV-VINORELBINE IN FIRST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 17:26:01